SIRT1 and metabolic syndrome: A strategy to reduce adiposity and dyslipidemia is based on the upregulation of peroxisome proliferator-activated receptor (PPARγ), peroxisome proliferator-activated receptor γ coactivator 1 α (PGC1α), and Sirtuin 1 (SIRT1).